Pharmaceutical Commercialization Solutions and Services
Growth Webinar - CDMO Growth Opportunities
Every leadership team has a strategy. Most have identified the right growth opportunities. Many have invested heavily in technology, AI, innovation, and transformation. Yet nearly 70% of strategic transformations fail to create lasting business value.
Why?
Because the real challenge is no longer strategy, it is implementation.
Click here to check out the leadership perspective from David Frigstad, Chairman & CEO, Frost & Sullivan.
Click here to access our whitepaper titled "The Connected CEO: Leading Through the Intelligence Revolution".
You can also explore our latest whitepaper titled "The Connected CEO: 10 Strategic Imperatives for the Intelligence Revolution" and join our exclusive webinar "Connected CEO: Top 10 Innovative Perspectives on the Intelligence Revolution" to learn more.
- Leverage LS RIM platforms to build a connected environment.
- Which leading organizations are benchmarked in this analysis?
- How are molecular complexity and patent expiries driving growth?
- Align with sustainability to strengthen your competitive edge.
- Assess the role of AI-enabled intelligence to improve patient care.
- Utilize the rising demand for CLIA-waived diagnostic solutions.
Introducing Frost & Sullivan’s Healthcare and Life Sciences LinkedIn Page
Transformation Growth Perspectives
Explore our growth-oriented whitepapers that translate industry disruption and strategic imperatives into actionable growth opportunities, competitive benchmarking, companies-to-action, and best practices to accelerate performance and drive sustainable competitive advantage.
Explore Executive Perspectives on Business Transformation
Interview with Elizabeth Koff
The Evolution from Enterprise Data Interoperability to Real-time Intelligence: Unlocking the Full Potential of Connected Care
Elizabeth Koff
Managing Director | Telstra Health
Interview with Farhoud Salimi
The Evolution from Enterprise Data Interoperability to Real-time Intelligence: Unlocking the Full Potential of Connected Care
Farhoud Salimi
Chief Technology Officer | Telstra Health
Interview with Ranjit Singh
Reimagining Healthcare Financing in Malaysia: Bridging the Gap Between Need and Affordability
Ranjit Singh
Founder & CEO | Amden Capital Sdn Bhd
Interview with Dr. Sven Abend
Building on Lactose Leadership: DFE Pharma’s Evolution into an Excipient Innovation Platform
Dr. Sven Abend
CEO | DFE Pharma
Interview with Dr. Baofu Zheng
From ADC Innovation to End-to-end CRDMO: ChemExpress’s Vision for the Next Phase of Growth
Dr. Baofu Zheng
Founder & CEO | ChemExpress
Interview with Kempton Presley
Humanizing Healthcare Innovation: How AI and Medication Adherence Are Advancing Value-based Care
Kempton Presley
Chief Executive Officer | AdhereHealth
Interview with Gregor Kawaletz
Democratizing Biologics: Building a More Accessible Future for Advanced Therapies
Gregor Kawaletz
CEO | Mabion
Navigating Transformation – Middle East (September 2026 Edition)
How can your organization thrive amidst the transformation of the ever-evolving NG911 and 5G industries?
Next Generation 911 in the United States
- How can you address growth gaps to outperform competitors in public safety?
- Capitalize on key prospects by aligning organizational design with innovations.
- Identify opportunities reshaping the next generation 911 (NG911) landscape.
Private 5G Network Landscape
- Are you equipped with new technologies to thrive amidst transformation?
- Maximize growth by harnessing networks to enhance performance.
- Align your strategy with megatrends reshaping private 5G networks.
Examine growth prospects in India's medtech space, capnography devices, and neuromodulation devices.

Learn more

Learn more

Learn more
Frost & Sullivan Brand and Demand Solutions

Capture growth across landscapes like the United States (US) population health management and healthcare cloud.
The Growth Innovation Leadership Council
How can your team grow rapidly in the ABM platform, content delivery network, and cloud service industries?
Frost & Sullivan welcomed more than 2,000 business leaders, policymakers, investors, academics and innovators to the 20th Growth, Innovation and Leadership (GIL) Summit in China, held August 4–5 at the Jing An Shangri-La in Shanghai.
Coinciding with Frost & Sullivan’s 65th anniversary, the summit featured more than 300 speakers and 150 keynote presentations and panel discussions. Topics included artificial intelligence, advanced manufacturing, semiconductors, life sciences, consumer markets and investment - highlighting the forces reshaping global competitiveness and transformational growth.
The event combined a flagship plenary programme with 10 parallel forums and the fifth edition of Frost & Sullivan’s New Investment Event, fostering collaboration across business, finance, government, academia and research.
How US Clinical Laboratory Services Are Adapting to a Changing Diagnostics Landscape
Clinical laboratories are processing more tests than ever before as aging populations, rising chronic disease prevalence, and advances in precision medicine and molecular diagnostics reshape healthcare delivery. However, increasing testing volumes alone will not define the next phase of US clinical laboratory services. Laboratories must also navigate reimbursement pressures, evolving regulatory requirements, payer consolidation, and growing demand for faster, more efficient diagnostic services.
How AI-integrated Biomarkers, Smart Automation, and Point-of-care Diagnostics Are Advancing Clinical Diagnostics
Today healthcare providers and diagnostics companies are looking for faster results, better workflow management, and wider access to testing services. Growing cancer cases, chronic diseases, and infectious disease concerns are increasing demand for decentralized molecular testing, tissue analysis, and combined chemistry-immunoassay testing systems.
Beyond the AI Hype: What HLTH Europe 2026 Revealed About Healthcare’s Next Phase
If HLTH Europe 2025 was dominated by discussions around AI’s potential, HLTH Europe 2026 highlighted the industry’s shift toward execution. AI dominated the agenda at the event, and the discussions revealed a notable shift in how the healthcare industry is approaching AI. Unlike previous years, where conversations largely centered on AI’s potential and emerging use cases, this year’s discussions reflected a more mature space.
Juno Health Receives the 2026 North American Modular EHR Delivery Customer Value Leadership Recognition for Excellence in Cloud-native EHR Innovation
We would like to congratulate Juno Health on earning Frost & Sullivan’s 2026 North American Customer Value Leadership Recognition in the modular electronic health record (EHR) delivery industry for its outstanding achievements in product innovation, customer experience, and healthcare technology modernization.
Frost & Sullivan: 65 Years of Identifying Growth Opportunities in Healthcare and Life Sciences
Helping Organizations Prepare for the Coming Transformation and Create Growth Opportunities Since 1961
Check out our exclusive infographic that explores detailed growth opportunities across healthcare AI & cloud technologies, healthcare RCM & telehealth, healthcare cybersecurity & patient engagement solutions, medical imaging informatics, cardiovascular, neurology, & surgical navigation, patient monitoring & medical wearables, point-of-care testing, laboratory automation, personalized therapies, and contract pharmaceutical services.
Check out the latest news covering key industry developments and major company highlights to stay up-to-date in the healthcare and life sciences landscape.
- Experimental Lilly combination drug tops Zepbound in weight-loss trial
- Healthcare software firm Waystar explores options including sale, sources say
- Novartis strikes up to $7.8 billion mRNA deal with China's Abogen
- Becton Dickinson pledges $19 billion US investment in deal with government
- GE HealthCare to Buy Sofie for Nearly $1 Billion to Grow Medical-Imaging Business
Frost & Sullivan Institute
Click Here to explore our latest blog on "FSI Visionary Growth Leadership Index: Healthcare Leaders Accelerating Access, Innovation, and Impact, Global 2026".
CUSTOMER ENGAGEMENT NEWSLETTER
Strategies and Tactics for Extraordinary Times
Subscribe Now to the monthly newsletter to explore major articles, insights, spotlight videos, upcoming events, council info and more.
THE INNOVATION NEWSLETTER
Inspiration and Best Practices to Help You Maximize Growth
Subscribe Now to the quarterly newsletter to access new articles, insights, spotlight blogs, upcoming events, council info and more.
Capture growth prospects across RNA therapy and neurogeneration landscapes.
Frost Growth Expert Network
Explore a wide range of Growth Webinars and Growth Podcasts highlighting emerging opportunities in the healthcare and life sciences landscape.
CDMO Live Americas
Dates: October 19-21, 2026
Venue: Boston
We're partnering with CDMO Live - the pharmaceutical industry's leading external manufacturing events series. CDMO Live connects pharma and biotech sponsors with contract manufacturing partners through focused conference sessions, networking, and the PartnerMatch meeting program that facilitates direct CDMO-sponsor connections.
Frost & Sullivan clients receive 20% off registration with code FROST20.
Future Health Summit
Dates: 20 – 22 October 2026
Venue: ADNEC Centre, Abu Dhabi
The Abu Dhabi Future Health Summit 2026, hosted by Future Health and the Department of Health – Abu Dhabi, takes place 20–22 October 2026 at ADNEC Centre Abu Dhabi. Bringing together global healthcare leaders, innovators, researchers, investors, and policymakers, the Summit will showcase advances in precision health, AI, longevity, and life sciences, while fostering insights, collaboration, partnerships, and healthcare transformation.
Global Health Exhibition
Dates: 26th - 29th October 2026
Venue: Malham, Riyadh, Saudi Arabia.
Established in 2018, Global Health Exhibition (GHE) is Saudi Arabia’s premier platform for driving healthcare transformation and innovation. Positioned as the global stage for healthcare evolution, GHE serves as a strategic meeting point for the world’s healthcare innovators, investors, and leaders. Organised by Tahaluf, a strategic alliance between Informa PLC, the Saudi Arabian Federation for Cyber Security and Programming (SAFCSP), and the Events Investment Fund (EIF), the event plays a pivotal role in advancing the Kingdom’s Vision 2030 Health Sector Transformation Program.
Hosted at the Riyadh Exhibition & Conference Center (Malham), GHE showcases groundbreaking technologies, including AI in diagnostics, genomic medicine, and telemedicine, while fostering public-private partnerships to reshape the future of healthcare in Saudi Arabia and beyond. Recognised for its excellence, GHE is an award-winning show, having been honored with the EN Awards for Best Trade Show over 10,000 SQM for its 2025 edition and previously awarded the AEO Best International Show – Middle East & Africa.
.
Bio Middle East
Dates: 14th to 16th December 2026
Venue: Riyadh Exhibition and Convention Centre, Malham, Saudi Arabia
BIO Middle East is the region’s dedicated biotechnology event, bringing together biotech innovators, pharmaceutical leaders, investors, researchers and policymakers. Taking place in Riyadh, Saudi Arabia, the event focuses on advancing biotechnology, biomanufacturing, precision medicine, investment and R&D partnerships, creating opportunities for collaboration and business growth across the Middle East and beyond.
The 20th Frost & Sullivan Global Growth, Innovation, and Leadership Summit and the 5th New Investment Event
Dates: 4-5 August 2026
Venue: Shanghai, China
On August 4-5, 2026, the 20th Frost & Sullivan Global Growth, Innovation and Leadership Summit and the 5th New Investment Event will have its grand opening at the Shangri La Hotel in Jing'an, Shanghai. This will also mark the 20th year milestone for Frost & Sullivan China to continue building on an international high-end communication platform for enterprises across China as well as the rest of the world.
CDMO Live Europe
Dates: May 19-21, 2026
Venue: Rotterdam
We're partnering with CDMO Live - the pharmaceutical industry's leading external manufacturing events series. CDMO Live connects pharma and biotech sponsors with contract manufacturing partners through focused conference sessions, networking, and the PartnerMatch meeting program that facilitates direct CDMO-sponsor connections.
Frost & Sullivan clients receive 20% off registration with code FROST20.
Medical Fair India 2026
Dates: 17 – 19 September 2026
Venue: Bombay Exhibition Center, Goregaon (E), Mumbai
Medical Fair India is an international trade fair, exhibition, and conference for hospitals, health centres, and clinics. It serves as a world-class platform for industry engagement, innovation, and collaboration. The show receives strong institutional support from leading industry associations and key healthcare stakeholders, including policymakers, innovators, medical device manufacturers, hospitals, tech start-ups, and researchers.
CDMO Live Americas
Dates: October 19-21, 2026
Venue: Boston
We're partnering with CDMO Live - the pharmaceutical industry's leading external manufacturing events series. CDMO Live connects pharma and biotech sponsors with contract manufacturing partners through focused conference sessions, networking, and the PartnerMatch meeting program that facilitates direct CDMO-sponsor connections.
Frost & Sullivan clients receive 20% off registration with code FROST20.
Dates: May 19-21, 2026
Venue: Rotterdam
We're partnering with CDMO Live - the pharmaceutical industry's leading external manufacturing events series that connects pharma and biotech sponsors with contract manufacturing partners through focused conference sessions, networking, and the PartnerMatch meeting program that facilitates direct CDMO-sponsor connections.
Frost & Sullivan clients receive 20% off registration with code FROST20.
Register Now
Dates: October 19-21, 2026
Venue: Boston
We're partnering with CDMO Live - the pharmaceutical industry's leading external manufacturing events series that connects pharma and biotech sponsors with contract manufacturing partners through focused conference sessions, networking, and the PartnerMatch meeting program that facilitates direct CDMO-sponsor connections.
Frost & Sullivan clients receive 20% off registration with code FROST20.
Register Now
Dates: 17 – 19 September 2026
Venue: Bombay Exhibition Center, Goregaon (E), Mumbai
Medical Fair India is an international trade fair, exhibition, and conference for hospitals, health centres, and clinics. It serves as a world-class platform for industry engagement, innovation, and collaboration. The show receives strong institutional support from leading industry associations and key healthcare stakeholders, including policymakers, innovators, medical device manufacturers, hospitals, tech start-ups, and researchers.
Register Now
Growth
Let's Talk About Your Project
Examine she brother prudent add day ham. Far stairs now coming bed oppose hunted become his. You zealously departure had procuring suspicion. Books whose front would purse if be do decay. Quitting you way formerly disposed perceive ladyship are.

